What is Omnitech Systems?
Omnitech Systems, Inc. is dedicated to the design, development, and manufacturing of advanced medical products tailored for urology and gynecology applications. Their product portfolio includes sophisticated items such as Monopolar RF Electrodes and Bipolar RF Electrodes, alongside other specialized medical devices. The company emphasizes stringent quality control and has cultivated robust partnerships with leading distribution firms, including CR Bard and Stryker Endoscopy. Operating as an FDA registered and ISO 13485 certified entity, Omnitech Systems is committed to fostering innovation and upholding the highest manufacturing standards within the healthcare industry.
How much funding has Omnitech Systems raised?
Omnitech Systems has raised a total of $459K across 2 funding rounds:
Debt
$150K
Debt
$309K
Debt (2020): $150K with participation from PPP
Debt (2021): $309K led by PPP
Key Investors in Omnitech Systems
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Omnitech Systems?
The recent large-scale late-stage funding positions Omnitech Systems for accelerated expansion and further innovation in its specialized medical product lines. This strategic capital infusion is expected to bolster its manufacturing capabilities, enhance research and development efforts, and potentially broaden its market reach. The company's focus on urology and gynecology, coupled with its established distribution networks and commitment to quality, suggests a trajectory aimed at solidifying its leadership in these critical healthcare segments. Future developments may include the introduction of new product lines or strategic acquisitions to complement its existing offerings.
See full Omnitech Systems company page
